| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/11/2004 | CN1519239A Ramification of a compound of medication as well as preparation method and application |
| 08/11/2004 | CN1519027A Biological preparation modified in plasma environment for treating liver disease and preparation method |
| 08/11/2004 | CN1519020A Combined medication of reduction typed glutathione and selenium compound |
| 08/11/2004 | CN1519018A Combination of medicine for treating hepatitis |
| 08/11/2004 | CN1519010A Grains of ginseng and astragalus root as well as preparing technique |
| 08/11/2004 | CN1519009A Medication for treating ulcer of oral cavity and preparation method |
| 08/11/2004 | CN1519006A Prepared Chinese medicine for treating fastidium of wean caused by deficient spleen and food stasis |
| 08/11/2004 | CN1519002A Extract product of Chinese traditional medicine as well as preparation method and application |
| 08/11/2004 | CN1518987A Now usage of polyunsaturated phosphatidylcholine |
| 08/11/2004 | CN1518984A Preparation of non-intestinal tract administration Adefovir and Adefovir Dipivixi |
| 08/11/2004 | CN1518983A Coordinated modication combination for anti hepatitis B virus |
| 08/11/2004 | CN1161355C New compounds |
| 08/11/2004 | CN1161351C Novel form of S-omeprazole |
| 08/11/2004 | CN1161345C 1,5-benzodiazepine derivatives ad CCK-A receptor agonists |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161143C Drop pills for toothache and its prepn. tech |
| 08/11/2004 | CN1161142C Medicinal composition for improving memory |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161137C Caspule for treating gastrosis |
| 08/11/2004 | CN1161132C Tibetan medicine for treating hepatism and its preparing process |
| 08/11/2004 | CN1161121C Alkaloid of matrine category utilized for mainline and its preparation method |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161021C Method of biological control |
| 08/10/2004 | US6774241 Ht3 receptor antagonists for nervous system, psychological, eating, and sleep disorder treatment |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774128 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (no) activity as measured in a standard gastric emptying assay |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6773912 Lantibiotic |
| 08/10/2004 | US6773720 Inner lipophilic and outher hydrophilic matrixs; high active ingredient content |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773627 Skin penetration enhancers; gels, dispersions, particles; hydrotrope, amphiphile and solvent |
| 08/05/2004 | WO2004065419A1 Antibody and use thereof |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065381A1 Process for making ondansetron and intermediates thereof |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004064851A1 Packs on the base of chalk and paraffin |
| 08/05/2004 | WO2004064843A2 Compound preparation for dizziness |
| 08/05/2004 | WO2004064823A1 Ceramide derivatives for the treatment of inflammation |
| 08/05/2004 | WO2004064721A2 A pyrazolopyrimidine compound and a process for preparing the same |
| 08/05/2004 | WO2004064717A2 Cop 1 for treatment of inflammatory bowel diseases |
| 08/05/2004 | WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 08/05/2004 | WO2004064713A2 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors |
| 08/05/2004 | WO2004064542A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | WO2004056804A3 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | US20040153126 Method and apparatus for treating uterine myoma |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152789 Complex of calcium compound and phosphate; adjustment pH |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152775 Using a compound containing a amine and a sulfinate group; gastrointestinal disorders |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152732 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152627 For therapy of orthopaedic and dental, including periodontal, diseases |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151708 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and anti-oxidative probiotic |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/05/2004 | DE10302688A1 Kreide-Paraffin-Packungen Chalk paraffin wraps |
| 08/05/2004 | CA2514153A1 Antibody and use thereof |
| 08/05/2004 | CA2513616A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | CA2513584A1 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors |
| 08/05/2004 | CA2511948A1 Combination of cinnarizine and dimenhydrinate for the treatment of vertigo as a consequence of vestibular neuropathy |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |